1-3 of 3
Fanny Lassalle, PharmD
Close
Sort by
Journal Articles

Value of Pre-Procedural Lymphocyte-to-Monocyte Ratio for Predicting New Cerebral Ischemic and Haemorrhagic Lesions Observed after Transcatheter Aortic Valve Implantation: A Pilot Study

Tom Denimal, Fanny Lassalle, PharmD, Nicolas Debry, MD, Antoine Rauch, MD PhD, Flavien Vincent, MD PhD, Bart Staels, PharmD, PhD, André Vincentelli, MD PhD, Sophie Susen, MD PhD, Eric Van Belle, MD PhD, Annabelle Dupont, PharmD, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3653.
https://doi.org/10.1182/blood-2019-126466
Published: 2019
Journal Articles

The Highly Prevalent Deletions in F8 Intron 13 Found in French Mild Haemophilia a Patients Result of Both Founder Effect and Recurrent De Novo Events

Yohann Jourdy, PhD PharmD, Mathilde Fretigny, PharmD, Fanny Lassalle, PharmD, David Lillicrap, MD, Claude Negrier, Patrice Bouvagnet, MD, Christine Vinciguerra, PharmD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2489.
https://doi.org/10.1182/blood-2018-99-111791
Published: 2018
Journal Articles

High-Throughput Genotyping of Haemophilia A and B Using Next-Generation Sequencing Technology in Lille University Hospital

Fanny Lassalle, PharmD, Antoine Rauch, MD PhD, Benedicte Wibaut, MD PhD, Christine Vinciguerra, PharmD, PhD, Mathilde Fretigny, PharmD, PhD, Bertrand Vaast, Valerie Gomanne, Sophie Susen, MD PhD, Jenny Goudemand, MD PhD, Christophe Zawadzki, PharmD, PhD
Journal: Blood
Blood (2015) 126 (23): 2273.
https://doi.org/10.1182/blood.V126.23.2273.2273
Published: 2015